Pds Biotechnology Corp Stock Investor Sentiment
| PDSB Stock | USD 1.36 0.01 0.74% |
About 55% of PDS Biotechnology's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding PDS Biotechnology Corp suggests that some traders are interested. The current market sentiment, together with PDS Biotechnology's historical and current headlines, can help investors time the market. In addition, many technical investors use PDS Biotechnology Corp stock news signals to limit their universe of possible portfolio assets.
Comfort Level 55
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use PDS Biotechnology's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward PDS Biotechnology Corp.
News SentimentBullish | Hype SentimentNeutral | Insider SentimentWaiting |
PDS Historical Sentiment
Although PDS Biotechnology's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding PDS, such as negative comments on social media and news outlets, may cause fear in the market and push PDS Biotechnology's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of PDS.
PDS |
PDS Biotechnology Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards PDS Biotechnology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about PDS Biotechnology that are available to investors today. That information is available publicly through PDS media outlets and privately through word of mouth or via PDS internal channels. However, regardless of the origin, that massive amount of PDS data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of PDS Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of PDS Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to PDS Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive PDS Biotechnology alpha.
PDS Biotechnology Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Iliev Ilian of 9000 shares of PDS Biotechnology at 3.9 subject to Rule 16b-3 | 12/24/2024 |
2 | Bigleaf Networks Unveils Pivotal 5G Connectivity Solution with BLR Edge 800W | 01/15/2025 |
3 | Acquisition by Glover Steve C of 9000 shares of PDS Biotechnology at 1.45 subject to Rule 16b-3 | 01/17/2025 |
4 | Acquisition by Glover Steve C of 9000 shares of PDS Biotechnology at 9.95 subject to Rule 16b-3 | 02/21/2025 |
5 | Insider Trading | 02/24/2025 |
6 | Calque Partners with EDGE Home Finance to Provide Buy-Before-You-Sell Programs That Convert Equity to Cash | 02/25/2025 |
7 | PDS Biotech Announces Positive Clinical Data Demonstrating Compelling Survival and Clinical Responses in RecurrentMetastatic HPV-Associated Cancers Published in... | 02/26/2025 |
8 | PDS Biotech Announces up to 22 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | 02/27/2025 |
9 | Acquisition by Glover Stephen C. of 15061 shares of PDS Biotechnology at 1.66 subject to Rule 16b-3 | 02/28/2025 |
10 | Acquisition by Freitag Gregory Gene of 15060 shares of PDS Biotechnology at 1.53 subject to Rule 16b-3 | 03/03/2025 |
11 | Insider Buying Gregory Freitag Acquires Additional Shares of PDS Biotechnology Corp | 03/04/2025 |
12 | PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evalu | 03/07/2025 |
13 | PDS Biotech Leadership to Participate in March Conferences | 03/11/2025 |
14 | PDS Biotech Announces FDA Clearance of IND Application for Combination of Versamune MUC1 and PDS01ADC to Treat Metastatic Colorectal Cancer | 03/13/2025 |
15 | CTERA Edge-to-Cloud File Services Now Available in Microsoft Azure Marketplace | 03/19/2025 |
Complementary Tools for PDS Stock analysis
When running PDS Biotechnology's price analysis, check to measure PDS Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PDS Biotechnology is operating at the current time. Most of PDS Biotechnology's value examination focuses on studying past and present price action to predict the probability of PDS Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PDS Biotechnology's price. Additionally, you may evaluate how the addition of PDS Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |